Effects of the Oral Administration of Mosapride Citrate on Capsule Endoscopy Completion Rate
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: In capsule endoscopy (CE), the capsule does not always reach the cecum within its battery life, which may reduce its diagnostic yield. We evaluated the effect of mosapride citrate, a 5-hydroxytryptamine-4 agonist that increases gastrointestinal motility, on CE completion. Methods: In a retrospective study, we performed univariate and multivariate analyses for 232 CE procedures performed at our hospital. To identify factors that affect CE completion, the following data were systematically collected: gender, age, gastric transit time (GTT), nonsteroidal anti-inflammatory drug administration, previous abdominal surgery, hospitalization, use of a polyethylene glycol solution, use of mosapride citrate (10 mg), body mass index (BMI), and total recording time. Results: The univariate analysis showed that oral mosapride citrate, GTT, and BMI were associated with improved CE completion. Multivariate analyses showed that oral mosapride citrate (odds ratio [OR], 1.99; 95% confidence interval [CI], 1.01 to 3.91) and GTT (OR, 2.34; 95% CI, 1.13 to 4.87) were significant factors for improving the CE completion. Oral mosapride citrate significantly shortened the GTT and small bowel transit time (SBTT). Conclusions: Oral mosapride citrate reduced the GTT and SBTT during CE and improved the CE completion rate.
Abstract
Background/Aims: In capsule endoscopy (CE), the capsule does not always reach the cecum within its battery life, which may reduce its diagnostic yield. We evaluated the effect of mosapride citrate, a 5-hydroxytryptamine-4 agonist that increases gastrointestinal motility, on CE completion. Methods: In a retrospective study, we performed univariate and multivariate analyses for 232 CE procedures performed at our hospital. To identify factors that affect CE completion, the following data were systematically collected: gender, age, gastric transit time (GTT), nonsteroidal anti-inflammatory drug administration, previous abdominal surgery, hospitalization, use of a polyethylene glycol solution, use of mosapride citrate (10 mg), body mass index (BMI), and total recording time. Results: The univariate analysis showed that oral mosapride citrate, GTT, and BMI were associated with improved CE completion. Multivariate analyses showed that oral mosapride citrate (odds ratio [OR], 1.99; 95% confidence interval [CI], 1.01 to 3.91) and GTT (OR, 2.34; 95% CI, 1.13 to 4.87) were significant factors for improving the CE completion. Oral mosapride citrate significantly shortened the GTT and small bowel transit time (SBTT). Conclusions: Oral mosapride citrate reduced the GTT and SBTT during CE and improved the CE completion rate.
참고문헌 (20)
- Iddan G, "Wireless capsule endoscopy", Nature, 405, pp.417~ (2000)
- Selby W, "Complete small-bowel transit in patients undergoing capsule endoscopy: determining factors and improvement with metoclopramide", Gastrointest Endosc, 61, pp.80~85 (2005)
- Albert JG, "Diagnosis of small bowel Crohn’s disease: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis", Gut, 54, pp.1721~1727 (2005)
- Trifan A, "Small bowel tumors in patients undergoing capsule endoscopy: a single center experience", J Gastrointestin Liver Dis, 19, pp.21~25 (2010)
- Ben-Soussan E, "Factors that affect gastric passage of video capsule", Gastrointest Endosc, 62, pp.785~790 (2005)
- Almeida N, "The effect of metoclopramide in capsule enteroscopy", Dig Dis Sci, 55, pp.153~157 (2010)
- Kalantzis C, "Effect of three bowel preparations on video-capsule endoscopy gastric and small-bowel transit time and completeness of the examination", Scand J Gastroenterol, 42, pp.1120~1126 (2007)
- Leung WK, "Effect of oral erythromycin on gastric and small bowel transit time of capsule endoscopy", World J Gastroenterol, 11, pp.4865~4868 (2005)
- Ogata H, "Clinical impact of a newly developed capsule endoscope: usefulness of a real-time image viewer for gastric transit abnormality", J Gastroenterol, 43, pp.186~192 (2008)
- Postgate A, "Are bowel purgatives and prokinetics useful for small-bowel capsule endoscopy? A prospective randomized controlled study", Gastrointest Endosc, 69, pp.1120~1128 (2009)
- Okamura K, "Effects of mosapride citrate, metoclopramide hydrochloride, lidocaine hydrochloride, and cisapride citrate on equine gastric emptying, small intestinal and caecal motility", Res Vet Sci, 86, pp.302~308 (2009)
- Wei W, "Effect of mosapride on gastrointestinal transit time and diagnostic yield of capsule endoscopy", J Gastroenterol Hepatol, 22, pp.1605~1608 (2007)
- Westerhof J, "Risk factors for incomplete small-bowel capsule endoscopy", Gastrointest Endosc, 69, pp.74~80 (2009)
- Triantafyllou K, "Video-capsule endoscopy gastric and small bowel transit time and completeness of the examination in patients with diabetes mellitus", Dig Liver Dis, 39, pp.575~580 (2007)
- Papadopoulos AA, "Effects of ageing on small bowel video-capsule endoscopy examination", Am J Gastroenterol, 103, pp.2474~2480 (2008)
- Scaglione G, "Age and video capsule endoscopy in obscure gastrointestinal bleeding: a prospective study on hospitalized patients", Dig Dis Sci, 56, pp.1188~1193 (2011)
- Endo H, "Abdominal surgery affects small bowel transit time and completeness of capsule endoscopy", Dig Dis Sci, 54, pp.1066~1070 (2009)
- Niv E, "Effect of erythromycin on image quality and transit time of capsule endoscopy: a two-center study", World J Gastroenterol, 14, pp.2561~2565 (2008)
- Schmelkin IJ, "Tegaserod decreases small bowel transit times in patients undergoing capsule endoscopy", Gastrointest Endosc, 59, pp.P176~ (2004)
- Kim KJ, "Tegaserod increase colonic entry rate in patients undergoing capsule endoscopy", Gastrointest Endosc, 61, pp.AB170~ (2005)